Advaxis, Inc. ADXS Company Overview Stock Message Board

New Post Public Reply Private Reply Replies (0) Message Board

Sep 1, 2013 at 12:05 AM

Advaxis, Inc. ADXS Company Overview

Stock Message Board http://investorshangout.com/search?q=ADXS&...mp;yt1=Go!

Advaxis, Inc. ADXS Current Price and Quotes
4.20
Previous Close
3.20
Open
3.25

Daily Range
4.52 - 3.25
52wk Range
19.38 - 2.60

Volume
59,123
Dividend
N/A

Average Vol (3m)
16,188
Yield
N/A

Advaxis, Inc. ADXS
Company Information
305 College Road East
Princeton, NJ 08540

Website: http://www.advaxis.com
Phone: 609-452-9813
Email: ir@advaxis.com
Find us on:

Advaxis, Inc. ADXS
Advaxis is a clinical-stage biotechnology company developing the next generation of immunotherapies for cancer and infectious diseases. Advaxis immunotherapies are based on a novel platform technology using live, attenuated bacteria that are bio-engineered to secrete an antigen/adjuvant fusion protein(s) that is designed to redirect the powerful immune response all human beings have to the bacterium to the cancer itself.
ADXS-HPV is currently being evaluated in four clinical trials for hum...

Advaxis, Inc. ADXS
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Apr 30, 2013 10-Q
CIK 0001100397
Fiscal Year End 10/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o Feb 01, 2012
Incorporated In: DE, USA
Year of Inc. 2002
Employees 12 a/o Mar 15, 2013
Company Officers/Contacts
Thomas Moore CEO
Daniel O'Connor EVP
Mark Rosenblum Senior VP, CFO, Secretary
Robert Petit Chief Scientific Officer
Company Directors
Thomas Moore Chairman
Ronie A. Appel
Richard Berman
Thomas McKearn
James Patton
David Sidransky
Company Notes
Note=1-31-05 company is in the development stage
Service Providers
Auditor/Accountant
Marcum LLP
750 Third Ave
New York, NY, 10017
United States

Legal Counsel
Not Available
Investor Relations Firm
Mission Investor Relations
3645 Marketplace Blvd.
Atlanta, GA, 30344
United States

Advaxis, Inc. ADXS
ADXS Security Details
Share Structure
Market Value1 $20,573,448 a/o Aug 30, 2013
Shares Outstanding 4,898,440 a/o Jul 26, 2013
Float Not Available
Authorized Shares 25,000,000 a/o Jul 15, 2013
Par Value Not Available
Shareholders
Shareholders of Record 93 a/o Feb 13, 2013
Security Notes
Capital Change=shs decreased by 1 for 125 split. Ex-date=07/15/2013.
Short Selling Data
Short Interest 1,077 (-0.46%)
Aug 15, 2013
Significant Failures to Deliver Yes - Reg SHO
Transfer Agent(s)
Securities Transfer Corp

Advaxis, Inc. ADXS Recent News

Aug 20, 2013 Advaxis Appoints Daniel J. O'Connor President and CEO and Elects Dr. James Patton Non-Executive Chairman of the Board
Aug 14, 2013 Advaxis' ADXS-HPV Granted Orphan Drug Designation for Treatment of HPV-Associated Anal Cancer
Aug 7, 2013 OTC Daily Alert Stock Watch - Advaxis, Inc. (OTCQB: ADXSD)
Jul 25, 2013 Advaxis Updates Business Outlook for 2013
Jul 17, 2013 Advaxis Announces ADXS-cHER2 Demonstrates Significant Survival Advantage in Ongoing Canine Osteosarcoma Study
Jul 16, 2013 Update on Advaxis Announces 1-for-125 Reverse Stock Split and Decrease in Authorized Shares of Common Stock
Jul 16, 2013 Advaxis Announces Appointment of New Member to Its Board of Directors
Jun 24, 2013 Advaxis Requests Orphan Drug Designation for Treatment of HPV-Associated Anal Cancer with ADXS-HPV
Jun 17, 2013 Advaxis Announces Voting Results of 2013 Annual Meeting of Stockholders
Jun 11, 2013 Advaxis Requests Orphan Drug Designation for Treatment of HPV-Associated Head and Neck Cancer with ADXS-HPV

12next >

Advaxis, Inc. ADXS Financials
Period Ending Oct 31, 2012 Oct 31, 2011 Oct 31, 2010 Oct 31, 2009
Total Revenue - - 508 30
Cost of Revenue - - - -
Gross Profit - - 508 30
Operating Expenses
Research and Development 6,646 8,079 4,904 2,316
Sales, General and Admin. 5,689 4,940 3,530 2,701
Non-Recurring Items - - - -
Other - - - -
Operating Income (12,335) (13,019) (7,926) (4,987)
Income From Continuing Operations
Add'l Income/Expense Items 4,455 9,223 650 5,845
Earnings Before Interest and Tax (7,880) (3,796) (7,276) 858
Interest Expense 4,537 4,699 3,815 851
Earnings Before Tax (12,416) (8,495) (11,091) 7
Income Tax (347) (379) (279) (922)
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (12,070) (8,116) (10,688) 929
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (12,070) (8,116) (10,812) 929
Preferred Stock and Other Adjustments (740) (1,539) - -
Net Income Applicable to Common Shareholders (12,810) (9,654) (10,812) 929

ADXS Advaxis, Inc. Research DD Guide

ADXS Advaxis, Inc. Stock Message Board http://investorshangout.com/search?q=ADXS&...mp;yt0=Go!
ADXS Advaxis, Inc. Stock Quote http://www.otcmarkets.com/stock/ADXS/quote
ADXS Advaxis, Inc. Stock Chart http://www.otcmarkets.com/stock/ADXS/chart
ADXS Advaxis, Inc. Company Info http://www.otcmarkets.com/stock/ADXS/company-info
ADXS Advaxis, Inc. Recent News http://www.otcmarkets.com/stock/ADXS/news
ADXS Advaxis, Inc. Financials http://www.otcmarkets.com/stock/ADXS/financials
ADXS Advaxis, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/ADXS/filings
ADXS Advaxis, Inc. Short Sales http://www.otcmarkets.com/stock/ADXS/short-sales
ADXS Advaxis, Inc. Insider Disclosure http://www.otcmarkets.com/stock/ADXS/insider-transactions
ADXS Advaxis, Inc. Research Reports http://www.otcmarkets.com/stock/ADXS/research
ADXS Advaxis, Inc. Summary http://finance.yahoo.com/q?s=ADXS
ADXS Advaxis, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=ADXS+Historical+Prices
ADXS Advaxis, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=ADXS
ADXS Advaxis, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=ADXS+Basic+Chart
ADXS Advaxis, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=ADXS+Basic+Tech.+Analysis
ADXS Advaxis, Inc. Headlines http://finance.yahoo.com/q/h?s=ADXS+Headlines
ADXS Advaxis, Inc. Press Releases http://finance.yahoo.com/q/p?s=ADXS+Press+Releases
ADXS Advaxis, Inc. Company Profile http://finance.yahoo.com/q/pr?s=ADXS+Profile
ADXS Advaxis, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=ADXS+Key+Statistics
ADXS Advaxis, Inc. Industry http://finance.yahoo.com/q/in?s=ADXS+Industry
ADXS Advaxis, Inc. Major Holders http://finance.yahoo.com/q/mh?s=ADXS+Major+Holders
ADXS Advaxis, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=ADXS+Insider+Transactions
ADXS Advaxis, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=ADXS+Insider+Roster
ADXS Advaxis, Inc. Income Statement http://finance.yahoo.com/q/is?s=ADXS
ADXS Advaxis, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=ADXS
ADXS Advaxis, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=ADXS+Cash+Flow&annual
ADXS Advaxis, Inc. Nasdaq http://www.nasdaq.com/symbol/ADXS
ADXS Advaxis, Inc. Market Watch http://www.marketwatch.com/investing/stock/ADXS
ADXS Advaxis, Inc. Bloomberg http://www.bloomberg.com/quote/ADXS:US
ADXS Advaxis, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=ADXS
ADXS Advaxis, Inc. Bussinessweek http://investing.businessweek.com/research/st...icker=ADXS
ADXS Advaxis, Inc. Barchart http://www.barchart.com/quotes/stocks/ADXS
ADXS Advaxis, Inc. OTC Short Report http://otcshortreport.com/index.php?index=ADXS
ADXS Advaxis, Inc. Investopedia http://www.investopedia.com/markets/stocks/ADXS/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

D2L Ventures into Vietnam with Van Lang Alliance

Unlocking New Frontiers in Vietnam's Education Well, looks like D2L is rolling into Vietnam with the kind of gusto you'd expect from a company that fancies itself a trailblazer in learning tech. This ain't just another humdrum expansion story; it's a five-year handshake with Van Lang Education Group that's got the tech firm dropping its anchor in a fresh and promising...

Decoding Love: The Real Patterns of Relationships

The Relationship Maze: More Than Meets the Eye Love ain't just a simple spark over a fancy dinner, let me tell you. In Dr. Bernadette Marson’s ‘The Relationship Code,’ she digs into seventy-seven elements gnawing at why relationships can crumble or thrive. It’s like a blueprint of human entanglements—a veritable explorer’s guide to the vast, wild creation we...

Alaska LNG Project Boosted by Strategic Positioning

Alaska LNG: Right Place, Right Time Someone bring out the confetti, because Paul Sullivan, Co-Chairman of Gastech, is celebrating Alaska LNG like it's 1999. And for good reason. If Alaska ever played its cards right, now's the moment according to the industry veteran. After Gastech 2026 wrapped its events in Bangkok last month, Sullivan laid out why the stars are aligning...

Spooky Suds: House of Horror Meets El Car Wash

A Haunted Wash Awaits Miami Drivers Picture this: you're cruising down West Flagler on a regular Wednesday evening, but tonight, you're not just rolling in for a rinse. Nope, this Wednesday night, the wash tunnel at El Car Wash gets downright spooky. It's getting a haunted house makeover with scare actors from the House of Horror. When a Car Wash Becomes a Haunted...

Senté’s Heparan Sulfate Pairing: Peer-Reviewed Success

Senté's Science-Driven Approach in Skincare Alright, cutting through the skincare noise, Senté Labs has pulled off something impressive—not just another jar of promises but actual, peer-reviewed science backing their Defense C Serum. Published in the Journal of Cosmetic Dermatology, this study isn't just talk about ingredients; it's a show of real results. This isn't...

Tenet® Beef: Revolutionizing Tenderness in America's Steaks

Cracking the Code: A Genetic Leap in Beef Tenderness Well, buckle up, folks, because Callipyge Genetics is shaking things up in the beef aisle with their genomic breakthrough, Tenet®. It's about time we see some real innovation in an industry that's, let's face it, been slow to evolve. This isn't just a flash in the pan—a bit of DNA parsing has uncovered how to...

LBT Unveils Game-Changing Cyclotron for Medical Advances

Unveiling the LB-30 Cyclotron at EANM 2026 Life in nuclear medicine never stands still, and once again, Longevous Beamtech (LBT) is stirring the pot with its brand-new LB-30 series medical cyclotron. They rolled out this high-powered beast at the 39th Annual Congress of the European Association of Nuclear Medicine (EANM 2026) in Vienna. Leaning into the 30 MeV energy...

eGlint's Rapid Tech Revolutionizes Proteomics with Win

A Game-Changer in Proteomics Now ain't this something—eGlint just scooped up the 2026 BioTools Innovator Grand Prize, waving a big ol' $250,000 check around and claiming the biotech spotlight with their swift-moving ProteoNex™ platform. Forget about sticking samples through sluggish labs and waiting an eternity; eGlint's tech is flipping the switch, serving up protein...

Art Print Paper: Finding the Perfect Match for Masterpieces

You ever stand in a gallery and notice how some art just lights up the room while others barely get a second glance? Well, a lot of that magic starts with an unsung hero—paper choice. I came across this bit from HelloNation diving into what makes paper selection a cornerstone for fine art prints. Now, I ain't an artist, but even a bruiser trader like me can see the...

Navigating Braces vs. Invisalign: Key Considerations

Choice Between Braces and Invisalign Isn't Straightforward When you're pondering over whether to go with braces or Invisalign, it ain't just a choice you make lightly over coffee. It's a nuanced decision that hinges on a multitude of factors as highlighted by orthodontic experts Dr. Erik Higginbottom and Dr. Kyle Higginbottom from Easton, MD, featured in HelloNation's...